Bayer AG (Germany) Performance
| BAYN Stock | EUR 23.42 0.54 2.25% |
On a scale of 0 to 100, Bayer AG holds a performance score of 14. The firm shows a Beta (market volatility) of 0.29, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bayer AG's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bayer AG is expected to be smaller as well. Please check Bayer AG's treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to make a quick decision on whether Bayer AG's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bayer AG NA are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Bayer AG reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 4.2 B | |
| Total Cashflows From Investing Activities | 855 M |
Bayer |
Bayer AG Relative Risk vs. Return Landscape
If you would invest 1,885 in Bayer AG NA on December 19, 2024 and sell it today you would earn a total of 457.00 from holding Bayer AG NA or generate 24.24% return on investment over 90 days. Bayer AG NA is generating 0.3897% of daily returns assuming 2.0722% volatility of returns over the 90 days investment horizon. Simply put, 18% of all stocks have less volatile historical return distribution than Bayer AG, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bayer AG Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bayer AG's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bayer AG NA, and traders can use it to determine the average amount a Bayer AG's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1881
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BAYN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.07 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Bayer AG is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bayer AG by adding it to a well-diversified portfolio.
Bayer AG Fundamentals Growth
Bayer Stock prices reflect investors' perceptions of the future prospects and financial health of Bayer AG, and Bayer AG fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bayer Stock performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 83.74 B | |||
| Shares Outstanding | 982.42 M | |||
| Price To Earning | 11.34 X | |||
| Price To Book | 1.37 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 44.08 B | |||
| EBITDA | 6.45 B | |||
| Cash And Equivalents | 8.19 B | |||
| Cash Per Share | 8.34 X | |||
| Total Debt | 35.55 B | |||
| Debt To Equity | 1.17 % | |||
| Book Value Per Share | 42.01 X | |||
| Cash Flow From Operations | 5.09 B | |||
| Earnings Per Share | 4.78 X | |||
| Total Asset | 120.24 B | |||
| Current Asset | 25.17 B | |||
| Current Liabilities | 16.68 B | |||
About Bayer AG Performance
By analyzing Bayer AG's fundamental ratios, stakeholders can gain valuable insights into Bayer AG's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bayer AG has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bayer AG has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER AG is traded on Frankfurt Stock Exchange in Germany.Things to note about Bayer AG NA performance evaluation
Checking the ongoing alerts about Bayer AG for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bayer AG NA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Bayer AG's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bayer AG's stock performance include:- Analyzing Bayer AG's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bayer AG's stock is overvalued or undervalued compared to its peers.
- Examining Bayer AG's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bayer AG's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bayer AG's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bayer AG's stock. These opinions can provide insight into Bayer AG's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bayer Stock analysis
When running Bayer AG's price analysis, check to measure Bayer AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer AG is operating at the current time. Most of Bayer AG's value examination focuses on studying past and present price action to predict the probability of Bayer AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer AG's price. Additionally, you may evaluate how the addition of Bayer AG to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |